Загрузка...
Cytokines that target immune killer cells against tumors
T-cell-stimulating cytokines have shown promise as monotherapies or in combination with other therapeutic modalities for immunotherapy of cancer. However, their efficacy is limited due to their short half-life, pleiotropic roles, and induction of severe toxicity even at therapeutic doses. To overcom...
Сохранить в:
| Опубликовано в: : | Cell Mol Immunol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7331613/ https://ncbi.nlm.nih.gov/pubmed/32523115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41423-020-0481-0 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|